Lymphoma Diffuse Large B-cell research hub

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

This study tests a new 'off-the-shelf' CAR-T cell therapy, Allo-QuadCAR01-T, for hard-to-treat B-cell cancers like lymphoma. It uses donor cells that target two cancer markers, aiming to be faster and potentially more effective than current treatments. Researchers will check its safety and how well it works.